Nathan Novotny
Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 12 | 2025 | 475 | 5.040 |
Why?
| | Robotic Surgical Procedures | 5 | 2025 | 182 | 2.020 |
Why?
| | Appendicitis | 6 | 2026 | 148 | 1.910 |
Why?
| | Herniorrhaphy | 6 | 2025 | 74 | 1.770 |
Why?
| | Appendectomy | 5 | 2020 | 89 | 1.630 |
Why?
| | Hernia, Inguinal | 4 | 2023 | 43 | 1.600 |
Why?
| | Simulation Training | 5 | 2026 | 134 | 1.560 |
Why?
| | Pyloric Stenosis, Hypertrophic | 3 | 2024 | 10 | 1.450 |
Why?
| | Pyloromyotomy | 2 | 2024 | 3 | 1.370 |
Why?
| | Foreign Bodies | 4 | 2022 | 107 | 1.310 |
Why?
| | General Surgery | 4 | 2026 | 207 | 1.310 |
Why?
| | Clinical Competence | 6 | 2026 | 1244 | 1.170 |
Why?
| | Disposable Equipment | 2 | 2020 | 24 | 1.160 |
Why?
| | Surgical Instruments | 2 | 2020 | 51 | 1.140 |
Why?
| | Retrospective Studies | 33 | 2026 | 17101 | 0.990 |
Why?
| | Pediatric Nursing | 1 | 2026 | 44 | 0.950 |
Why?
| | Chest Tubes | 1 | 2026 | 34 | 0.950 |
Why?
| | Duodenal Obstruction | 1 | 2025 | 6 | 0.920 |
Why?
| | Formative Feedback | 1 | 2026 | 31 | 0.920 |
Why?
| | Surgical Stapling | 1 | 2025 | 16 | 0.910 |
Why?
| | Anastomosis, Surgical | 2 | 2025 | 157 | 0.910 |
Why?
| | Wounds, Nonpenetrating | 3 | 2023 | 316 | 0.890 |
Why?
| | Duodenum | 1 | 2025 | 77 | 0.880 |
Why?
| | Magnets | 3 | 2022 | 21 | 0.880 |
Why?
| | Feedback | 1 | 2026 | 181 | 0.880 |
Why?
| | Colectomy | 1 | 2025 | 107 | 0.870 |
Why?
| | Abdominal Injuries | 2 | 2023 | 127 | 0.860 |
Why?
| | Suture Techniques | 1 | 2025 | 131 | 0.850 |
Why?
| | Hernia, Femoral | 1 | 2024 | 4 | 0.840 |
Why?
| | Needs Assessment | 2 | 2026 | 404 | 0.800 |
Why?
| | Tracheoesophageal Fistula | 2 | 2022 | 38 | 0.780 |
Why?
| | Child | 32 | 2026 | 22657 | 0.760 |
Why?
| | Internship and Residency | 5 | 2026 | 1257 | 0.750 |
Why?
| | Peritoneum | 2 | 2023 | 45 | 0.710 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2022 | 70 | 0.700 |
Why?
| | Colitis, Ulcerative | 1 | 2023 | 148 | 0.680 |
Why?
| | Gastroschisis | 1 | 2021 | 32 | 0.670 |
Why?
| | Digestive System Surgical Procedures | 1 | 2022 | 110 | 0.660 |
Why?
| | Rural Population | 1 | 2025 | 650 | 0.640 |
Why?
| | Humans | 68 | 2026 | 144957 | 0.630 |
Why?
| | Bronchoscopy | 2 | 2018 | 227 | 0.630 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 62 | 0.620 |
Why?
| | Operative Time | 4 | 2025 | 175 | 0.620 |
Why?
| | Thoracoscopy | 1 | 2020 | 62 | 0.610 |
Why?
| | Bronchi | 2 | 2018 | 267 | 0.600 |
Why?
| | Biological Products | 1 | 2023 | 252 | 0.600 |
Why?
| | Caustics | 1 | 2019 | 6 | 0.590 |
Why?
| | Accidents, Home | 1 | 2019 | 33 | 0.590 |
Why?
| | Esophageal Diseases | 1 | 2019 | 30 | 0.580 |
Why?
| | Postoperative Complications | 6 | 2026 | 2920 | 0.580 |
Why?
| | Burns, Chemical | 1 | 2019 | 32 | 0.580 |
Why?
| | Adjuvants, Anesthesia | 1 | 2018 | 13 | 0.570 |
Why?
| | Patient Satisfaction | 2 | 2020 | 705 | 0.560 |
Why?
| | Female | 41 | 2026 | 78376 | 0.560 |
Why?
| | Developing Countries | 4 | 2024 | 318 | 0.560 |
Why?
| | Midazolam | 1 | 2018 | 72 | 0.550 |
Why?
| | Needles | 1 | 2018 | 62 | 0.540 |
Why?
| | Postoperative Care | 1 | 2020 | 288 | 0.540 |
Why?
| | Tracheal Neoplasms | 1 | 2017 | 12 | 0.540 |
Why?
| | Neurilemmoma | 1 | 2017 | 25 | 0.530 |
Why?
| | Child, Preschool | 16 | 2025 | 11799 | 0.530 |
Why?
| | Infant | 13 | 2025 | 10039 | 0.520 |
Why?
| | Metals, Rare Earth | 1 | 2017 | 3 | 0.520 |
Why?
| | Gastrostomy | 2 | 2009 | 130 | 0.520 |
Why?
| | Cautery | 1 | 2017 | 4 | 0.520 |
Why?
| | Inguinal Canal | 1 | 2017 | 11 | 0.520 |
Why?
| | Quality Improvement | 1 | 2026 | 1291 | 0.510 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 271 | 0.510 |
Why?
| | Male | 35 | 2026 | 72406 | 0.510 |
Why?
| | Rare Diseases | 1 | 2017 | 113 | 0.500 |
Why?
| | Esophagus | 1 | 2019 | 261 | 0.500 |
Why?
| | Global Health | 1 | 2019 | 401 | 0.460 |
Why?
| | Abdomen | 2 | 2023 | 141 | 0.460 |
Why?
| | Trachea | 1 | 2017 | 261 | 0.460 |
Why?
| | Treatment Outcome | 13 | 2026 | 11695 | 0.450 |
Why?
| | Anesthesia | 1 | 2018 | 258 | 0.430 |
Why?
| | Catheters, Indwelling | 2 | 2011 | 96 | 0.390 |
Why?
| | Patient-Centered Care | 1 | 2018 | 544 | 0.390 |
Why?
| | Recurrence | 5 | 2026 | 1135 | 0.390 |
Why?
| | Length of Stay | 6 | 2026 | 1337 | 0.390 |
Why?
| | Stem Cell Transplantation | 3 | 2008 | 191 | 0.380 |
Why?
| | Sepsis | 2 | 2009 | 641 | 0.370 |
Why?
| | Adolescent | 16 | 2026 | 22453 | 0.370 |
Why?
| | Robotics | 2 | 2023 | 87 | 0.350 |
Why?
| | Omentum | 1 | 2011 | 9 | 0.340 |
Why?
| | Neutropenia | 1 | 2011 | 155 | 0.320 |
Why?
| | Michigan | 3 | 2025 | 136 | 0.320 |
Why?
| | Rectus Abdominis | 1 | 2009 | 16 | 0.300 |
Why?
| | Peritoneal Dialysis | 1 | 2011 | 100 | 0.300 |
Why?
| | Angiopoietin-1 | 1 | 2009 | 12 | 0.300 |
Why?
| | Longevity | 1 | 2011 | 173 | 0.300 |
Why?
| | Infant, Newborn | 6 | 2025 | 6434 | 0.290 |
Why?
| | Compartment Syndromes | 1 | 2009 | 36 | 0.290 |
Why?
| | Fissure in Ano | 1 | 2008 | 4 | 0.290 |
Why?
| | Barium Radioisotopes | 1 | 2008 | 2 | 0.290 |
Why?
| | Barium | 1 | 2008 | 27 | 0.290 |
Why?
| | Estrogens | 2 | 2008 | 380 | 0.290 |
Why?
| | Fundoplication | 1 | 2009 | 54 | 0.280 |
Why?
| | Peptic Ulcer | 1 | 2008 | 18 | 0.280 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2008 | 80 | 0.280 |
Why?
| | Intestinal Volvulus | 1 | 2007 | 23 | 0.260 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 250 | 0.260 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 167 | 0.250 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2009 | 557 | 0.250 |
Why?
| | Practice Patterns, Physicians' | 2 | 2026 | 1358 | 0.250 |
Why?
| | Pilonidal Sinus | 1 | 2026 | 4 | 0.240 |
Why?
| | Neuroblastoma | 1 | 2008 | 174 | 0.240 |
Why?
| | Gastroesophageal Reflux | 1 | 2009 | 236 | 0.240 |
Why?
| | Injury Severity Score | 3 | 2023 | 600 | 0.240 |
Why?
| | Gastric Bypass | 1 | 2007 | 125 | 0.230 |
Why?
| | Duodenostomy | 1 | 2025 | 3 | 0.230 |
Why?
| | Ischemia | 1 | 2009 | 421 | 0.230 |
Why?
| | Adult | 12 | 2026 | 40506 | 0.230 |
Why?
| | Intestinal Atresia | 1 | 2025 | 17 | 0.230 |
Why?
| | Resuscitation Orders | 1 | 2025 | 48 | 0.220 |
Why?
| | Personal Autonomy | 1 | 2025 | 59 | 0.220 |
Why?
| | Analgesia | 1 | 2026 | 105 | 0.220 |
Why?
| | Interleukin-6 | 2 | 2008 | 780 | 0.220 |
Why?
| | DNA Damage | 1 | 2008 | 430 | 0.220 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 621 | 0.220 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2026 | 136 | 0.210 |
Why?
| | Thrombophilia | 1 | 2025 | 88 | 0.210 |
Why?
| | NF-kappa B | 1 | 2008 | 662 | 0.210 |
Why?
| | Spleen | 2 | 2023 | 508 | 0.210 |
Why?
| | Analgesics | 1 | 2026 | 231 | 0.200 |
Why?
| | Thrombelastography | 1 | 2025 | 178 | 0.200 |
Why?
| | Intestinal Obstruction | 1 | 2024 | 56 | 0.200 |
Why?
| | Obesity, Morbid | 1 | 2007 | 281 | 0.200 |
Why?
| | Education, Medical, Graduate | 2 | 2026 | 557 | 0.200 |
Why?
| | Drug Prescriptions | 1 | 2025 | 285 | 0.200 |
Why?
| | Mediastinal Emphysema | 1 | 2023 | 9 | 0.200 |
Why?
| | Esophageal Perforation | 1 | 2023 | 15 | 0.200 |
Why?
| | Antibiotic Prophylaxis | 1 | 2024 | 129 | 0.190 |
Why?
| | Intestine, Small | 1 | 2024 | 166 | 0.190 |
Why?
| | Biological Factors | 1 | 2023 | 39 | 0.190 |
Why?
| | Splenic Artery | 1 | 2022 | 13 | 0.190 |
Why?
| | Hospitals, Pediatric | 2 | 2024 | 557 | 0.190 |
Why?
| | Follow-Up Studies | 4 | 2023 | 5417 | 0.190 |
Why?
| | Morbidity | 2 | 2022 | 323 | 0.190 |
Why?
| | Anesthesiology | 1 | 2025 | 175 | 0.190 |
Why?
| | Lacerations | 1 | 2023 | 40 | 0.190 |
Why?
| | Esophagoplasty | 1 | 2022 | 2 | 0.190 |
Why?
| | Infliximab | 1 | 2023 | 108 | 0.190 |
Why?
| | Faculty, Medical | 1 | 2026 | 303 | 0.180 |
Why?
| | Urban Population | 1 | 2025 | 491 | 0.180 |
Why?
| | Silicones | 1 | 2022 | 29 | 0.180 |
Why?
| | Surveys and Questionnaires | 4 | 2026 | 6053 | 0.180 |
Why?
| | Remission Induction | 1 | 2023 | 308 | 0.180 |
Why?
| | Esophageal Atresia | 1 | 2022 | 30 | 0.180 |
Why?
| | Spectrometry, Fluorescence | 1 | 2022 | 168 | 0.170 |
Why?
| | Aging | 3 | 2008 | 1966 | 0.170 |
Why?
| | Prognosis | 2 | 2021 | 4293 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2024 | 316 | 0.170 |
Why?
| | Contrast Media | 1 | 2024 | 488 | 0.170 |
Why?
| | Oxidative Stress | 1 | 2008 | 1339 | 0.170 |
Why?
| | Radiation Exposure | 1 | 2021 | 63 | 0.170 |
Why?
| | Middle East | 1 | 2020 | 18 | 0.160 |
Why?
| | Myocardial Infarction | 1 | 2008 | 1209 | 0.160 |
Why?
| | Clostridium Infections | 1 | 2021 | 74 | 0.160 |
Why?
| | Time | 1 | 2020 | 86 | 0.160 |
Why?
| | Radiography | 3 | 2019 | 845 | 0.150 |
Why?
| | Developed Countries | 1 | 2019 | 38 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 41 | 0.150 |
Why?
| | Transforming Growth Factor alpha | 2 | 2009 | 56 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2019 | 58 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 294 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2009 | 128 | 0.140 |
Why?
| | Laryngeal Masks | 1 | 2018 | 18 | 0.140 |
Why?
| | Cross Infection | 1 | 2021 | 262 | 0.140 |
Why?
| | Deep Sedation | 1 | 2018 | 16 | 0.140 |
Why?
| | Age Distribution | 1 | 2019 | 403 | 0.140 |
Why?
| | Tomography, X-Ray Computed | 4 | 2026 | 2738 | 0.140 |
Why?
| | Critical Pathways | 1 | 2019 | 108 | 0.140 |
Why?
| | Pylorus | 1 | 2017 | 17 | 0.130 |
Why?
| | Thoracotomy | 1 | 2018 | 83 | 0.130 |
Why?
| | Cervical Vertebrae | 1 | 2019 | 158 | 0.130 |
Why?
| | Intestines | 1 | 2021 | 358 | 0.130 |
Why?
| | Electrocoagulation | 1 | 2017 | 36 | 0.130 |
Why?
| | Stents | 1 | 2022 | 556 | 0.130 |
Why?
| | Fluoroscopy | 1 | 2018 | 176 | 0.130 |
Why?
| | Umbilicus | 1 | 2017 | 17 | 0.130 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 427 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5872 | 0.130 |
Why?
| | Cost Savings | 1 | 2017 | 86 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 636 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2025 | 1143 | 0.120 |
Why?
| | Lipopolysaccharides | 3 | 2009 | 863 | 0.120 |
Why?
| | Delayed Diagnosis | 1 | 2017 | 95 | 0.120 |
Why?
| | Middle Aged | 4 | 2025 | 35928 | 0.120 |
Why?
| | Cicatrix | 1 | 2017 | 69 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2020 | 901 | 0.120 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 343 | 0.120 |
Why?
| | Airway Obstruction | 1 | 2017 | 162 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2023 | 957 | 0.110 |
Why?
| | Liver | 1 | 2023 | 1888 | 0.100 |
Why?
| | Family | 1 | 2018 | 679 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1915 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1495 | 0.100 |
Why?
| | Hospitalization | 1 | 2024 | 2434 | 0.100 |
Why?
| | Surgeons | 1 | 2017 | 340 | 0.100 |
Why?
| | Animals | 11 | 2009 | 38109 | 0.090 |
Why?
| | Risk Factors | 3 | 2024 | 10792 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2019 | 728 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 81 | 0.090 |
Why?
| | Paracrine Communication | 2 | 2008 | 67 | 0.090 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2008 | 59 | 0.080 |
Why?
| | Animals, Newborn | 3 | 2008 | 902 | 0.080 |
Why?
| | Stomach Diseases | 1 | 2010 | 20 | 0.080 |
Why?
| | Jejunum | 1 | 2010 | 35 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2008 | 4569 | 0.080 |
Why?
| | Cytokines | 2 | 2009 | 2065 | 0.080 |
Why?
| | Equipment Failure | 1 | 2011 | 115 | 0.080 |
Why?
| | Stomach | 1 | 2010 | 109 | 0.080 |
Why?
| | Hypertension | 2 | 2009 | 1264 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1186 | 0.080 |
Why?
| | Mice | 6 | 2009 | 18365 | 0.080 |
Why?
| | Receptor Cross-Talk | 1 | 2009 | 21 | 0.080 |
Why?
| | Gastroscopy | 1 | 2009 | 18 | 0.080 |
Why?
| | Laparotomy | 1 | 2009 | 112 | 0.070 |
Why?
| | Propanolamines | 1 | 2009 | 40 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2009 | 4155 | 0.070 |
Why?
| | Pancreatic Elastase | 1 | 2008 | 55 | 0.070 |
Why?
| | Infusions, Intra-Arterial | 1 | 2008 | 61 | 0.070 |
Why?
| | Tumor Necrosis Factors | 1 | 2008 | 10 | 0.070 |
Why?
| | Pressure | 1 | 2009 | 225 | 0.070 |
Why?
| | Orchiectomy | 1 | 2008 | 74 | 0.070 |
Why?
| | Aorta, Abdominal | 1 | 2008 | 52 | 0.070 |
Why?
| | Trauma Centers | 2 | 2023 | 462 | 0.070 |
Why?
| | Adult Stem Cells | 1 | 2008 | 39 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 966 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2008 | 51 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2008 | 27 | 0.070 |
Why?
| | Aged | 2 | 2025 | 25947 | 0.070 |
Why?
| | Comet Assay | 1 | 2008 | 14 | 0.070 |
Why?
| | Young Adult | 3 | 2023 | 14126 | 0.070 |
Why?
| | Electrophoresis | 1 | 2008 | 31 | 0.070 |
Why?
| | Endotoxins | 1 | 2009 | 221 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 7191 | 0.070 |
Why?
| | Rats | 4 | 2008 | 5614 | 0.070 |
Why?
| | Anus, Imperforate | 1 | 2007 | 24 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 529 | 0.070 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2008 | 137 | 0.070 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 194 | 0.070 |
Why?
| | Enema | 1 | 2007 | 46 | 0.070 |
Why?
| | Steroids | 1 | 2008 | 160 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 252 | 0.070 |
Why?
| | Curriculum | 2 | 2025 | 1060 | 0.060 |
Why?
| | Models, Animal | 1 | 2009 | 392 | 0.060 |
Why?
| | Random Allocation | 1 | 2008 | 363 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 292 | 0.060 |
Why?
| | Stem Cells | 2 | 2008 | 627 | 0.060 |
Why?
| | Probability | 1 | 2008 | 312 | 0.060 |
Why?
| | Gonadal Steroid Hormones | 1 | 2008 | 144 | 0.060 |
Why?
| | Enteral Nutrition | 1 | 2009 | 216 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 2008 | 294 | 0.060 |
Why?
| | Models, Biological | 3 | 2009 | 1822 | 0.060 |
Why?
| | Fecal Incontinence | 1 | 2007 | 91 | 0.060 |
Why?
| | Bone Marrow | 1 | 2008 | 306 | 0.060 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 216 | 0.060 |
Why?
| | Reference Values | 1 | 2008 | 798 | 0.060 |
Why?
| | Administration, Oral | 1 | 2009 | 848 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 381 | 0.060 |
Why?
| | Mice, Nude | 1 | 2008 | 688 | 0.060 |
Why?
| | Ketorolac | 1 | 2026 | 30 | 0.060 |
Why?
| | Ventricular Remodeling | 1 | 2008 | 276 | 0.060 |
Why?
| | Incidence | 2 | 2024 | 2883 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 386 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2008 | 5997 | 0.060 |
Why?
| | Reperfusion Injury | 1 | 2008 | 300 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2009 | 3125 | 0.050 |
Why?
| | Kidney Failure, Chronic | 1 | 2011 | 598 | 0.050 |
Why?
| | Estradiol | 1 | 2008 | 533 | 0.050 |
Why?
| | Testosterone | 1 | 2008 | 419 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2024 | 34 | 0.050 |
Why?
| | Cardiac Catheterization | 1 | 2008 | 560 | 0.050 |
Why?
| | Heart | 1 | 2008 | 636 | 0.050 |
Why?
| | Myocardium | 1 | 2009 | 939 | 0.050 |
Why?
| | Hemodynamics | 1 | 2009 | 1121 | 0.050 |
Why?
| | Glucose | 1 | 2009 | 1049 | 0.050 |
Why?
| | Wound Healing | 1 | 2026 | 351 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2118 | 0.050 |
Why?
| | Splenomegaly | 1 | 2022 | 14 | 0.050 |
Why?
| | Reoperation | 1 | 2026 | 631 | 0.050 |
Why?
| | Morals | 1 | 2024 | 80 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1990 | 0.050 |
Why?
| | Splenectomy | 1 | 2022 | 65 | 0.050 |
Why?
| | Play and Playthings | 1 | 2022 | 35 | 0.050 |
Why?
| | Ultrasonography | 1 | 2026 | 770 | 0.040 |
Why?
| | Thrombosis | 1 | 2025 | 393 | 0.040 |
Why?
| | Gestational Age | 1 | 2024 | 975 | 0.040 |
Why?
| | Ligation | 1 | 2020 | 92 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2022 | 201 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 530 | 0.040 |
Why?
| | Prospective Studies | 2 | 2025 | 7997 | 0.040 |
Why?
| | United States | 3 | 2022 | 15988 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2022 | 237 | 0.040 |
Why?
| | Research Design | 1 | 2026 | 1137 | 0.040 |
Why?
| | Eating | 1 | 2022 | 392 | 0.040 |
Why?
| | Communication | 1 | 2025 | 967 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1031 | 0.030 |
Why?
| | Signal Transduction | 2 | 2008 | 5233 | 0.030 |
Why?
| | Computer Simulation | 1 | 2022 | 1026 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2880 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2024 | 947 | 0.030 |
Why?
| | Transfection | 2 | 2009 | 940 | 0.030 |
Why?
| | Hypertension, Pulmonary | 1 | 2008 | 1980 | 0.030 |
Why?
| | RNA, Small Interfering | 2 | 2009 | 635 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 732 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3608 | 0.030 |
Why?
| | Quality of Life | 1 | 2007 | 3192 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1486 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 949 | 0.030 |
Why?
| | Heart Failure | 1 | 2008 | 2323 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2026 | 2313 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1217 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7183 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2019 | 853 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2925 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2008 | 2540 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5965 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1839 | 0.020 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2010 | 26 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3676 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2008 | 27 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2008 | 52 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 41 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 153 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 313 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 73 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 125 | 0.020 |
Why?
| | Cardiac Output | 1 | 2008 | 179 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 173 | 0.020 |
Why?
| | Osteoblasts | 1 | 2008 | 145 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2008 | 298 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2008 | 217 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 476 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 376 | 0.020 |
Why?
| | Tibia | 1 | 2008 | 176 | 0.020 |
Why?
| | Adipocytes | 1 | 2008 | 223 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1048 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 285 | 0.010 |
Why?
| | Femur | 1 | 2008 | 250 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 319 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 826 | 0.010 |
Why?
| | Tissue Engineering | 1 | 2008 | 442 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2008 | 365 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1733 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 556 | 0.010 |
Why?
| | Fibroblasts | 1 | 2008 | 1034 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 2114 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2008 | 870 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 970 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3335 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2430 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1642 | 0.010 |
Why?
|
|
Novotny's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|